Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists.

Front Endocrinol (Lausanne) · 2021 · PMC7996095 · PMID 33776913

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, the microadenoma exhibited an increasing trend (0.9 * 0.8 * 0.7 cm, Figures 1A, B ), although the dose of CAB increased to 4 mg/w ( Figure S1 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.